|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Shire's_oncology_business_(2018)
|
|
gptkbp:businessModel
|
Non-profit foundation ownership
|
|
gptkbp:CEO
|
gptkb:Olivier_Laureau
|
|
gptkbp:country
|
gptkb:France
|
|
gptkbp:founded
|
1954
|
|
gptkbp:founder
|
gptkb:Jacques_Servier
|
|
gptkbp:hasResearchCenter
|
gptkb:Servier_BioInnovation_(Boston,_USA)
gptkb:Servier_Research_Institute_(France)
gptkb:Servier_Research_and_Development_(Budapest,_Hungary)
|
|
gptkbp:headquarters_location
|
gptkb:Suresnes
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Servier
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:language
|
gptkb:French
English
|
|
gptkbp:legalForm
|
Foundation-owned
|
|
gptkbp:member
|
gptkb:International_Federation_of_Pharmaceutical_Manufacturers_&_Associations
gptkb:European_Federation_of_Pharmaceutical_Industries_and_Associations
|
|
gptkbp:notable_drug
|
gptkb:Valdoxan
gptkb:Trimetazidine
gptkb:Fenspiride
gptkb:Glimepiride
gptkb:Ivabradine
gptkb:Molidustat
gptkb:Perindopril
|
|
gptkbp:notableCase
|
Mediator (benfluorex) litigation
|
|
gptkbp:notableEvent
|
gptkb:Mediator_scandal
|
|
gptkbp:notablePerson
|
gptkb:Jacques_Servier
gptkb:Olivier_Laureau
|
|
gptkbp:number_of_countries_present
|
150+
|
|
gptkbp:numberOfEmployees
|
~22,000
|
|
gptkbp:operatesIn
|
Worldwide
|
|
gptkbp:partner
|
gptkb:Taiho_Pharmaceutical
gptkb:Novartis_(oncology_collaboration)
Cellectis (CAR-T cell therapy)
|
|
gptkbp:products
|
Prescription medicines
Generic medicines
Cardiovascular drugs
Diabetes drugs
Neuropsychiatric drugs
Oncology drugs
|
|
gptkbp:R&D_investment
|
~20% of revenue
|
|
gptkbp:researchInterest
|
Cardiology
Oncology
Diabetes
Neuropsychiatry
Immuno-inflammation
|
|
gptkbp:revenue
|
~4.9 billion euros (2022)
|
|
gptkbp:stockExchange
|
Not publicly traded
|
|
gptkbp:subsidiary
|
gptkb:Egis_Pharmaceuticals
gptkb:Servier_Laboratories_Limited_(UK)
gptkb:Servier_Pharmaceuticals_(USA)
|
|
gptkbp:type
|
Private, non-listed company
|
|
gptkbp:website
|
https://servier.com
|
|
gptkbp:bfsParent
|
gptkb:Servier_(oncology_business,_2021)
gptkb:PhRMA
|
|
gptkbp:bfsLayer
|
6
|